Applied Therapeutics, Inc. Profile Avatar - Palmy Investing

Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatmen…

Biotechnology
US, New York [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of APLT's Analysis
CIK: 1697532 CUSIP: 03828A101 ISIN: US03828A1016 LEI: - UEI: -
Secondary Listings
APLT has no secondary listings inside our databases.